Pfizer was offering $118 billion in U.S. cash for AstraZeneca in an offer it said was a take-it-or-leave-it deal. But as in politics, it is rarely really over when big business must live or die by growing. At AstraZeneca, and the places where they have factories, like the UK and Sweden, there was concern expressed about whether Pfizer would eliminate jobs. And yet, the AstraZeneca board was saying that if Pfizer just paid a bit more, they might have a deal. AstraZeneca makes such well-known products as Nexium, Plavix and Crestor. Reuters
